Gamida Cell Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.20%35.140.9%$1166.99m
JNJJohnson & Johnson 0.81%146.390.7%$997.10m
BMYBristol-Myers Squibb Co. -0.17%57.651.0%$908.42m
MRKMerck & Co., Inc. 0.74%77.930.7%$754.01m
ABBVAbbVie, Inc. 1.64%98.271.9%$713.64m
LLYEli Lilly & Co. 0.86%163.471.1%$633.15m
AZNAstraZeneca Plc 0.71%53.621.2%$289.35m
RPRXRoyalty Pharma Plc 0.09%44.100.1%$183.56m
NVSNovartis AG 0.72%86.700.2%$140.42m
RGENRepligen Corp. -0.86%121.467.1%$109.69m
GSKGlaxoSmithKline Plc 0.50%40.270.2%$106.52m
NVONovo Nordisk A/S -0.12%65.070.1%$83.31m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.89%71.560.0%$64.14m
RETAReata Pharmaceuticals, Inc. -3.74%147.323.4%$63.80m
SNYSanofi 2.06%51.990.2%$62.42m

Company Profile

Gamida Cell Ltd. is a clinical stage biopharmaceutical company engaging in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.